163 related articles for article (PubMed ID: 7559661)
1. Regulation of cytochrome P450 2C11 (CYP2C11) gene expression by interleukin-1, sphingomyelin hydrolysis, and ceramides in rat hepatocytes.
Chen J; Nikolova-Karakashian M; Merrill AH; Morgan ET
J Biol Chem; 1995 Oct; 270(42):25233-8. PubMed ID: 7559661
[TBL] [Abstract][Full Text] [Related]
2. Bimodal regulation of ceramidase by interleukin-1beta. Implications for the regulation of cytochrome p450 2C11.
Nikolova-Karakashian M; Morgan ET; Alexander C; Liotta DC; Merrill AH
J Biol Chem; 1997 Jul; 272(30):18718-24. PubMed ID: 9228043
[TBL] [Abstract][Full Text] [Related]
3. Suppression of the constitutive expression of cytochrome P-450 2C11 by cytokines and interferons in primary cultures of rat hepatocytes: comparison with induction of acute-phase genes and demonstration that CYP2C11 promoter sequences are involved in the suppressive response to interleukins 1 and 6.
Chen JQ; Ström A; Gustafsson JA; Morgan ET
Mol Pharmacol; 1995 May; 47(5):940-7. PubMed ID: 7538197
[TBL] [Abstract][Full Text] [Related]
4. Regulation of hepatic cytochrome P450 2C11 via cAMP: implications for down-regulation in diabetes, fasting, and inflammation.
Iber H; Li-Masters T; Chen Q; Yu S; Morgan ET
J Pharmacol Exp Ther; 2001 Apr; 297(1):174-80. PubMed ID: 11259542
[TBL] [Abstract][Full Text] [Related]
5. Suppression of constitutive cytochrome P450 gene expression by epidermal growth factor receptor ligands in cultured rat hepatocytes.
Ching KZ; Tenney KA; Chen J; Morgan ET
Drug Metab Dispos; 1996 May; 24(5):542-6. PubMed ID: 8723734
[TBL] [Abstract][Full Text] [Related]
6. Nitric oxide-independent suppression of P450 2C11 expression by interleukin-1beta and endotoxin in primary rat hepatocytes.
Sewer MB; Morgan ET
Biochem Pharmacol; 1997 Sep; 54(6):729-37. PubMed ID: 9310350
[TBL] [Abstract][Full Text] [Related]
7. Activation of sphingolipid turnover and chronic generation of ceramide and sphingosine in liver during aging.
Lightle SA; Oakley JI; Nikolova-Karakashian MN
Mech Ageing Dev; 2000 Dec; 120(1-3):111-25. PubMed ID: 11087909
[TBL] [Abstract][Full Text] [Related]
8. Sphingolipid-dependent signaling in regulation of cytochrome P450 expression.
Morgan ET; Nikolova-Karakashian M; Chen JQ; Merrill AH
Methods Enzymol; 1996; 272():381-8. PubMed ID: 8791797
[No Abstract] [Full Text] [Related]
9. Down-regulation of cytochrome P450 2C family members and positive acute-phase response gene expression by peroxisome proliferator chemicals.
Corton JC; Fan LQ; Brown S; Anderson SP; Bocos C; Cattley RC; Mode A; Gustafsson JA
Mol Pharmacol; 1998 Sep; 54(3):463-73. PubMed ID: 9730905
[TBL] [Abstract][Full Text] [Related]
10. Effects of metyrapone on expression of CYPs 2C11, 3A2, and other 3A genes in rat hepatocytes cultured on matrigel.
Goodwin B; Liddle C; Murray M; Tapner M; Rooney T; Farrell GC
Biochem Pharmacol; 1996 Jul; 52(2):219-27. PubMed ID: 8694846
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-1 beta stimulates sphingomyelin hydrolysis in cultured granulosa cells: evidence for a regulatory role of ceramide on progesterone and prostaglandin biosynthesis.
Santana P; Llanes L; Hernandez I; Gonzalez-Robayna I; Tabraue C; Gonzalez-Reyes J; Quintana J; Estevez F; Ruiz de Galarreta CM; Fanjul LF
Endocrinology; 1996 Jun; 137(6):2480-9. PubMed ID: 8641202
[TBL] [Abstract][Full Text] [Related]
12. Fibronectin-mediated hepatocyte shape change reprograms cytochrome P450 2C11 gene expression via an integrin-signaled induction of ribonuclease activity.
Hodgkinson CP; Wright MC; Paine AJ
Mol Pharmacol; 2000 Nov; 58(5):976-81. PubMed ID: 11040044
[TBL] [Abstract][Full Text] [Related]
13. Suppression of CYP2C11 gene transcription by interleukin-1 mediated by NF-kappaB binding at the transcription start site.
Iber H; Chen Q; Cheng PY; Morgan ET
Arch Biochem Biophys; 2000 May; 377(1):187-94. PubMed ID: 10775459
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional suppression of cytochrome P450 2C11 gene expression by 3-methylcholanthrene.
Lee C; Riddick DS
Biochem Pharmacol; 2000 Jun; 59(11):1417-23. PubMed ID: 10751551
[TBL] [Abstract][Full Text] [Related]
15. Hormonal regulation of microsomal cytochrome P450 2C11 in rat liver and kidney.
Chen GF; Ronis MJ; Thomas PE; Flint DJ; Badger TM
J Pharmacol Exp Ther; 1997 Dec; 283(3):1486-94. PubMed ID: 9400025
[TBL] [Abstract][Full Text] [Related]
16. Impact of tamoxifen on peripubertal androgen imprinting of rat hepatic cytochrome P450 2C11, cytochrome P450 3A2, and steroid 5 alpha-reductase.
Chang TK; Chan MM; Holsmer SL; Bandiera SM; Bellward GD
Biochem Pharmacol; 1996 Feb; 51(3):357-68. PubMed ID: 8573203
[TBL] [Abstract][Full Text] [Related]
17. Regulation of constitutive rat hepatic cytochromes P450 by 3-methylcholanthrene.
Jones EJ; Riddick DS
Xenobiotica; 1996 Oct; 26(10):995-1012. PubMed ID: 8905915
[TBL] [Abstract][Full Text] [Related]
18. Expression of a male-specific cytochrome P450 isozyme (CYP2C11) in fa/fa Zucker rats: effect of phenobarbital treatment.
Bandyopadhyay AM; Chaudhary I; Robertson LW; Gemzik B; Parkinson A; Blouin RA
Arch Biochem Biophys; 1993 Dec; 307(2):386-90. PubMed ID: 8274026
[TBL] [Abstract][Full Text] [Related]
19. Regulation of hepatic cytochrome P450 2C11 by transforming growth factor-beta, hepatocyte growth factor, and interleukin-11.
Iber H; Morgan ET
Drug Metab Dispos; 1998 Oct; 26(10):1042-4. PubMed ID: 9763412
[TBL] [Abstract][Full Text] [Related]
20. Regulation of cytochrome P450 expression by sphingolipids.
Merril AH; Nikolova-Karakashian M; Schmelz EM; Morgan ET; Stewart J
Chem Phys Lipids; 1999 Nov; 102(1-2):131-9. PubMed ID: 11001567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
